Charles River Associates

Since 1965, we’ve delivered thoughtful, effective advice backed by research and real-world experience.

Rare Disease: 2024 in review

Projects have spanned a wide range of therapeutic areas and modalities, drawing on our cross-functional expertise in strategy, policy, analytics, and litigation.

Read the year in review
CRA announces vice president promotions

We are proud to announce the promotions of eight new vice presidents.

Learn more
CMA clears acquisition of Teads by Outbrain

The CMA announced the unconditional clearance of Outbrain’s acquisition of Teads, a deal assisted by a CRA team, following clearances in other jurisdictions.

Read the engagement
2024 International Arbitration review: Updates and trends

Work spanned sectors including energy, mining and commodities, life sciences and pharma, technology, and quantum, as well as shareholder disputes and post-M&A arbitrations.

Learn more here
Ann Arbor municipalization study

The study reveals significant financial and operational challenges associated with the transition to a municipal utility.

Read more here
Rare Disease: 2024 in review

Projects have spanned a wide range of therapeutic areas and modalities, drawing on our cross-functional expertise in strategy, policy, analytics, and litigation.

Read the year in review
CRA announces vice president promotions

We are proud to announce the promotions of eight new vice presidents.

Learn more

Stay informed with our latest insights.

Connect with us at conferences, seminars, and webinars.

Read our case studies to see the problems we’ve solved and results we’ve delivered.

We’re always looking for high-performers to join our team of experts.

CRA